EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 97 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $122 | -56.7% | 400 | 0.0% | 0.00% | – |
| Q2 2023 | $282 | -21.4% | 400 | 0.0% | 0.00% | – |
| Q1 2023 | $359 | -23.9% | 400 | 0.0% | 0.00% | – |
| Q4 2022 | $472 | -84.3% | 400 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | +50.0% | 400 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -99.9% | 400 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $3,540,000 | +70700.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +66.7% | 400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | -25.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | +33.3% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -75.0% | 400 | -50.0% | 0.00% | -50.0% |
| Q4 2019 | $12,000 | +140.0% | 800 | +68.1% | 0.00% | 0.0% |
| Q3 2019 | $5,000 | – | 476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |